Structure-Guided Design, Synthesis, and Evaluation of Guanine-Derived Inhibitors of the eIF4E mRNA–Cap Interaction

Citations Over TimeTop 10% of 2012 papers

Abstract

The eukaryotic initiation factor 4E (eIF4E) plays a central role in the initiation of gene translation and subsequent protein synthesis by binding the 5' terminal mRNA cap structure. We designed and synthesized a series of novel compounds that display potent binding affinity against eIF4E despite their lack of a ribose moiety, phosphate, and positive charge as present in m7-GMP. The biochemical activity of compound 33 is 95 nM for eIF4E in an SPA binding assay. More importantly, the compound has an IC(50) of 2.5 μM for inhibiting cap-dependent mRNA translation in a rabbit reticular cell extract assay (RRL-IVT). This series of potent, truncated analogues could serve as a promising new starting point toward the design of neutral eIF4E inhibitors with physicochemical properties suitable for cellular activity assessment.

Related Papers

• → Structure and functions of the translation initiation factor eIF4E and its role in cancer development and treatment(2018)67 cited
• → Eukaryotic initiation factor 4E(2007)68 cited
• → Requirement of the eukaryotic translation initiation factor 4F complex in hepatitis E virus replication(2015)29 cited
• → Design of Cell-Permeable Inhibitors of Eukaryotic Translation Initiation Factor 4E (eIF4E) for Inhibiting Aberrant Cap-Dependent Translation in Cancer(2023)16 cited
• → Dysregulation of amino acid metabolism upon rapid depletion of cap-binding protein eIF4E(2023)1 cited